Xiaonian Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xiaonian Zhu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Ruyuan Liu
Guangxi Key Laboratory of Environmental Exposomics and Entire Lifecycle Health, Guilin Medical University, Guilin 541199, Guangxi, China
2 shared publicationsYuanyuan Huang
Guangxi Key Laboratory of Environmental Exposomics and Entire Lifecycle Health, Guilin Medical University, Guilin 541199, Guangxi, China
2 shared publicationsCheng Lin
Guangxi Clinical Medical Research Center for Hepatobiliary Diseases, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise 533000, Guangxi, China
1 shared publicationDI Li
Department of Health Toxicology School of Public Health Guilin Medical University 541199 Guilin China
1 shared publicationDi Li
Guangxi Key Laboratory of Environmental Exposomics and Entire Lifecycle Health, Guilin Medical University, Guilin 541199, Guangxi, China
1 shared publicationGuangzi Qi
Guangxi Clinical Medical Research Center for Hepatobiliary Diseases, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise 533000, Guangxi, China
1 shared publication
Latest Publications
- 25 April 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 156, 114733
Dihydroartemisinin alleviates diethylnitrosamine-induced hepatocarcinogenesis by targeting a novel MAZ/TRIM50 axis
- 25 April 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 156, 114733
Dihydroartemisinin alleviates diethylnitrosamine-induced hepatocarcinogenesis by targeting a novel MAZ/TRIM50 axis
- Open Access
- 1 January 2023
- Published by Tech Science Press in BIOCELL
- Vol. 47 (3) , 485-491
Research progress of protein phosphatase 2A in cellular autophagy
Autophagy is an important metabolic process. It facilitates the recycling of intracellular substances by removing, degrading, and recycling damaged organelles, proteins, and lipids in lysosomal vacuoles and plays an important role in maintaining cellular homeostasis. Protein phosphatase 2A (PP2A) is a key serine/threonine phosphatase and one of the main cell cycle regulatory enzymes. As PP2A activity is essential for the cell, dysfunction or dysregulation of PP2A can affect various physiological processes, including autophagy. Here, we review the autophagy-related factors that target PP2A in different diseases, such as breast cancer, colorectal cancer, liver cancer, and Alzheimer’s disease, to maintain cell homeostasis by modulating the level of autophagy through mTORC1/ULK1 pathway, MAPK pathway, or AMPK pathway.
- 1 January 2023
- Published by Tech Science Press in BIOCELL
- Vol. 47 (3) , 485-491
Open AccessResearch progress of protein phosphatase 2A in cellular autophagy
Autophagy is an important metabolic process. It facilitates the recycling of intracellular substances by removing, degrading, and recycling damaged organelles, proteins, and lipids in lysosomal vacuoles and plays an important role in maintaining cellular homeostasis. Protein phosphatase 2A (PP2A) is a key serine/threonine phosphatase and one of the main cell cycle regulatory enzymes. As PP2A activity is essential for the cell, dysfunction or dysregulation of PP2A can affect various physiological processes, including autophagy. Here, we review the autophagy-related factors that target PP2A in different diseases, such as breast cancer, colorectal cancer, liver cancer, and Alzheimer’s disease, to maintain cell homeostasis by modulating the level of autophagy through mTORC1/ULK1 pathway, MAPK pathway, or AMPK pathway.